Callan JMB Inc.

CJMB · NasdaqCM · Stock · Industrials
$2.17
+0.93% today
Delayed price,

What Callan JMB does

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology. In addition, the company engages in oil and gas development business. Callan JMB Inc. has strategic partnership with Alabama State University to advance the United States pharmaceutical manufacturing and supply chain resilience. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

Key facts

Sector
Industrials
Industry
Integrated Freight & Logistics
Market cap
$14.4M
P/E (ttm)
—
Forward P/E
—
Dividend yield
0.00%
Beta
—
Profit margin
-192.0%
Employees
18
Headquarters
Spring Branch, TX, United States
Exchange
NasdaqCM

Performance

1 Month
-4.8%
3 Months
+77.9%
6 Months
+80.8%
1 Year
-49.4%
5 Years
-51.7%
$0.6552-week range$5.61
Biggest setback — last 12 months
-83.3%
13 Oct 2025 → 15 Jun 2026
Fell from $4.29 to $0.72 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+255.2%
15 Jun 2026 → 20 Jul 2026
Ran from $0.72 to $2.55 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$1.41 (-35.1%)$2.17$3.35 (+54.2%)
3 Months$1.03 (-52.8%)$2.17$4.59 (+111.7%)
6 Months$0.75 (-65.4%)$2.17$6.27 (+188.8%)
12 Months$0.48 (-77.7%)$2.17$9.73 (+348.2%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 150.0%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent insider activity

Acquired 10,000 shares at $0.76 — Dial Gerald, Director · 2026-06-01
Acquired 10,195 shares at $1.75 — Croyle David J, Chief Medical Officer · 2026-03-26
Acquired 14,805 shares at $1.76 — Croyle David J, Chief Medical Officer · 2026-03-10
Acquired 2,000 shares at $1.20 — Dial Gerald, Director · 2026-01-06
Acquired 5,000 shares at $1.73 — Williams Wayne D, CEO, Chairman and President · 2025-12-18
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.